BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 33864941)

  • 1. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Dingemans AC; Früh M; Ardizzoni A; Besse B; Faivre-Finn C; Hendriks LE; Lantuejoul S; Peters S; Reguart N; Rudin CM; De Ruysscher D; Van Schil PE; Vansteenkiste J; Reck M;
    Ann Oncol; 2021 Jul; 32(7):839-853. PubMed ID: 33864941
    [No Abstract]   [Full Text] [Related]  

  • 2. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Früh M; De Ruysscher D; Popat S; Crinò L; Peters S; Felip E;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi99-105. PubMed ID: 23813929
    [No Abstract]   [Full Text] [Related]  

  • 3. Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Sørensen M; Felip E;
    Ann Oncol; 2009 May; 20 Suppl 4():71-2. PubMed ID: 19454469
    [No Abstract]   [Full Text] [Related]  

  • 4. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Sørensen M; Pijls-Johannesma M; Felip E;
    Ann Oncol; 2010 May; 21 Suppl 5():v120-5. PubMed ID: 20555060
    [No Abstract]   [Full Text] [Related]  

  • 5. Looking ahead to new therapies in small cell lung cancer.
    Rudin CM
    Clin Adv Hematol Oncol; 2018 Apr; 16(4):269-272. PubMed ID: 29742081
    [No Abstract]   [Full Text] [Related]  

  • 6. Lung Cancer OncoGuia.
    ; Manchon Walsh P; Manchon P; Borràs JM; Ferro T; Espinàs JA
    Clin Transl Oncol; 2009 Dec; 11(12):805-24. PubMed ID: 20045787
    [No Abstract]   [Full Text] [Related]  

  • 7. Small cell lung cancer. Clinical practice guidelines in oncology.
    National, Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2004 Mar; 2(2):134-57. PubMed ID: 19777703
    [No Abstract]   [Full Text] [Related]  

  • 8. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Vansteenkiste J; De Ruysscher D; Eberhardt WE; Lim E; Senan S; Felip E; Peters S;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi89-98. PubMed ID: 23860613
    [No Abstract]   [Full Text] [Related]  

  • 9. Lung cancer.
    Thai AA; Solomon BJ; Sequist LV; Gainor JF; Heist RS
    Lancet; 2021 Aug; 398(10299):535-554. PubMed ID: 34273294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timeliness of lung cancer diagnosis and treatment: a single-center experience.
    Rao SS; Saha S
    Asian Cardiovasc Thorac Ann; 2019 Oct; 27(8):670-676. PubMed ID: 31569945
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    D'Addario G; Felip E;
    Ann Oncol; 2008 May; 19 Suppl 2():ii39-40. PubMed ID: 18456762
    [No Abstract]   [Full Text] [Related]  

  • 12. Small cell lung cancer.
    Nat Rev Dis Primers; 2021 Jan; 7(1):4. PubMed ID: 33446659
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors associated with timeliness of post-primary care referral, diagnosis and treatment for lung cancer: population-based, data-linkage study.
    Forrest LF; Adams J; White M; Rubin G
    Br J Cancer; 2014 Oct; 111(9):1843-51. PubMed ID: 25203519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of care and survival among small cell lung cancer patients: Experience from a tertiary center in India.
    Julka PK; Sharma DN; Madan R; Mallick S; Benson R; Kunhi P H; Gupta S; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):47-51. PubMed ID: 27856126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of patients presenting to a dedicated rapid access lung cancer clinic.
    Dunican E; Uzbeck M; Clince J; Toner S; Royston D; Logan MP; Breathnach O; Young V; Linnane SI; Morgan RK
    Ir Med J; 2011 Oct; 104(9):265-8. PubMed ID: 22132593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Postmus PE; Kerr KM; Oudkerk M; Senan S; Waller DA; Vansteenkiste J; Escriu C; Peters S;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv1-iv21. PubMed ID: 28881918
    [No Abstract]   [Full Text] [Related]  

  • 17. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
    National Lung Screening Trial Research Team
    J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Reck M; Popat S; Reinmuth N; De Ruysscher D; Kerr KM; Peters S;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii27-39. PubMed ID: 25115305
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
    Hendriks LE; Kerr KM; Menis J; Mok TS; Nestle U; Passaro A; Peters S; Planchard D; Smit EF; Solomon BJ; Veronesi G; Reck M;
    Ann Oncol; 2023 Apr; 34(4):358-376. PubMed ID: 36669645
    [No Abstract]   [Full Text] [Related]  

  • 20. Small cell lung cancer.
    Kalemkerian GP; Akerley W; Bogner P; Borghaei H; Chow L; Downey RJ; Gandhi L; Ganti AK; Govindan R; Grecula JC; Hayman J; Heist RS; Horn L; Jahan TM; Koczywas M; Moran CA; Niell HB; O'Malley J; Patel JD; Ready N; Rudin CM; Williams CC;
    J Natl Compr Canc Netw; 2011 Oct; 9(10):1086-113. PubMed ID: 21975911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.